Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
University of Ferrara rejected a journalist’s FOI request about the investigation of its own Rector. The arguments: the media is biased and drives a slander campaign against Giorgio Zauli, and in any case, his research can only be evaluated in a “Science Court” by peer review.
Katrin Amunts is director of Human Brain Project. Back when the Berlin Wall fell, this Moscow-trained young neuroscientist from GDR found a new mentor in Western Germany: Professor Karl Zilles. It is a remarkable story of a literal brain drain.
The emails published here prove that EU Special Envoy for OA, Robert Jan Smits, received constant counselling from Frontiers CEO Kamila Markram when designing Plan S. It seems, Frontiers and Smits share exactly same vision for the future of scholarly publishing.
Cancer researcher Giorgio Zauli publicly declared himself exonerated because he simply forbids his University of Ferrara to publish the investigative report. The ultra-right connected rector used the occasion to equal his critics to Nazis and to announce defamation lawsuits.
The new ERC President Mauro Ferrari used to closely collaborate with two very controversial cancer researchers at MD Anderson in Texas: Anil Sood and Gabriel Lopez-Beerestein. Will that experience affect ERC’s already wanting stance on research integrity?
Frédérique Vidal has been professor for molecular genetics and rector of the University of Nice before she became the currently serving cabinet Minister of Higher Education, Research and Innovation in France. The French government keeps responding with threats of legal action to earlier evidence of data irregularities in her published research, this is why I publish more such evidence here.
The 2008 Lancet paper of Paolo Macchiarini and Martin Birchall about the world first trachea transplant might end up retracted. Until recently, the journal’s editor Richard Horton used to ignore and suppress “non peer-reviewed” evidence, but due to combined pressure of activism, media and politics, things started to move.
The trachea-transplanting company Videregen, based in Liverpool, got another £2 million grant from UK governmental agency Innovate UK, to advance their tracheal replacement technology.
Manipulated data in 17 papers from one cancer research lab in China gets flagged on PubPeer. It ends with the university hospital in Wuhan issuing a secret statement accusing the US pharma giant a Merck of a conspiracy to slander a Chinese Academy member, Dr Ding Ma.
Plan S, designed by the former EU Commissioner Robert-Jan Smits, became a complete and chaotic mess where everyone, including the members of the signatory cOAlition S of research founders, does whatever they want. I learned all that while participating at the Academic Publishing Europe (APE) conference in Berlin, on 15-16 January.
